Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 12, 2024 | Back issues
Courthouse News Service Courthouse News Service


SmithKlineBeecham knew but failed to warn that its diabetes drug Rosiglitazone, aka Avandia, Amaryl and Avandaryl, could cause heart attacks, strokes and death, a class-action complaint claims in Sacramento Federal Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.